Contents

Search

rhinitis medicamentosa

Etiology: - rhinitis secondary to chronic use of decongestants or improper or excessive application of nasal preparation(s) Epidemiology: - may be less common that than previously thought [1] Pathology: - tolerance to decongestants (i.e. nasal vascoconstrictors such as oxymetazoline) leads to diminished effect with continued use, but worsening of nasal congestion with stopping its use Management: - stop offending agent - nasal glucocorticoids or nasal saline rinses may mitigate symptoms of decongestant withdrawal

General

rhinitis

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 16, 18 American College of Physicians, Philadelphia 2012, 2018
  2. Doshi J. Rhinitis medicamentosa: what an otolaryngologist needs to know. Eur Arch Otorhinolaryngol. 2009 May;266(5):623-5 PMID: 19096862
  3. NEJM Knowledge+ Otolaryngology - Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-55. PMID: 16784007 Free article. Review. - Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngol Head Neck Surg. 2019 Dec 9;48(1):70. PMID: 31818321 PMCID: PMC6902618 Free PMC article.